Healthcare Medical Devices Biotechnology

Active Pharmaceutical Ingredients Market Report Cover

Active Pharmaceutical Ingredients Market

Active Pharmaceutical Ingredients Market Report Cover

Active Pharmaceutical Ingredients Market Size, Share, Growth & Industry Analysis, By Type (Generic API, Branded API), By Synthesis (Synthetic, Biotech), By Manufacturer (Captive APIs, Merchant APIs), By Type(Prescription, OTC) and Regional Analysis, 2024-2031

Author : Ashim L.

Pages : 120

Base Year : 2023

Release : May 2024

Report ID: KR668

Active Pharmaceutical Ingredients Market Size

The global Active Pharmaceutical Ingredients Market size was valued at USD 215.67 billion in 2023 and is projected to reach USD 323.29 billion by 2031, growing at a CAGR of 5.38% from 2024 to 2031. In the scope of work, the report includes products offered by companies such as Pfizer Inc., Novartis International AG, Bristol-Myers Squibb, BASF SE, Boehringer Ingelheim GmbH, ELI Lilly and Company, Merck & Co., Inc., Abbvie Inc., Sanofi Inc., GlaxoSmithKline PLC, and others.

The active pharmaceutical ingredients (API) market includes the production and distribution of the chemical compounds used as active components in pharmaceutical drugs. It is a critical sector within the pharmaceutical industry, supplying APIs for a wide range of therapeutic applications. Key factors driving market expansion include increasing demand for generic drugs following patent expirations, growing prevalence of chronic diseases, advancements in drug delivery technologies, and rising healthcare expenditures globally. The API market is characterized by stringent regulatory requirements, intense competition, ongoing research and development (R&D) for innovative therapies, and a growing focus on quality and safety standards.

Additionally, globalization and the expansion of pharmaceutical manufacturing capabilities in emerging markets are contributing to market growth and evolution. Active pharmaceutical ingredients (APIs) consist of the actual biomolecule or compound that exhibit pharmacological activities, thus producing the desired health effects. For Instance, Tylenol, a popular over-the-counter analgesic medicine, has acetaminophen/paracetamol as the active pharmaceutical ingredient. These ingredients can be made from various sources, including plants, animals, or produced synthetically in labs. Pharmaceutical companies mix APIs with other substances to create the final medicine in forms such as tablets or liquids. APIs are critical in drug development and manufacturing, determining the quality and effectiveness of the medication.

Analyst’s Review 

The active pharmaceutical ingredient (API) market is experiencing robust growth, propelled by increasing demand for generic drugs and advancements in biotechnology. As the global population ages and the prevalence of chronic diseases rises, the need for efficient and cost-effective medications becomes increasingly critical. Innovations in drug development and manufacturing technologies are enhancing API quality and production efficiency, offering lucrative opportunities for industry players. However, stringent regulatory requirements are crucial to ensure that the rise in demand and production capacity does not impact the quality of the product.

Active Pharmaceutical Ingredients Market Growth Factors

The development of the API market is driven by a growing demand for generic drugs, especially as patents for branded medications reach expiration. Pharmaceutical companies rely heavily on APIs to manufacture cost-effective generic versions of popular drugs, thereby meeting the demands of healthcare systems and patients for affordable treatment options. This demand is fueled by several factors such as rising healthcare costs, expanding access to healthcare globally, and government initiatives to promote generic drug usage, resulting in significant market growth.

The API market is impacted by continuous advancements in drug delivery technologies. Innovative drug formulations, such as controlled-release formulations, nanomedicines, and targeted therapies, require specialized APIs that deliver the drug effectively to the target site in the body. This drives the development and production of complex APIs with specific functionalities, thus increasing demand in the API market. Additionally, advancements in drug delivery technologies enhance patient compliance, improve therapeutic outcomes, and expand the scope of drug treatments, thereby stimulating the growth of the API market.

Active Pharmaceutical Ingredients Market Trends

There is a growing emphasis on specialty APIs, which are complex molecules used in niche therapeutic areas such as oncology, immunology, and rare diseases. Pharmaceutical companies are investing heavily in the development and production of these specialized APIs to address unmet medical needs and capitalize on the high-value segments of the pharmaceutical market. This reflects a shift toward personalized medicine and targeted therapies, leading to increased demand for APIs with specific functionalities.

The global expansion of manufacturing capabilities and increased outsourcing of API production are supporting the growth of the API market. Pharmaceutical companies are leveraging cost advantages and expertise in regions such as Asia-Pacific, particularly in countries such as India and China, for API manufacturing. Outsourcing allows companies to focus on core competencies, reduce manufacturing costs, and access specialized capabilities and technologies. This fosters collaboration and partnerships across regions, driving efficiency, innovation, and competitiveness in the API market, all while meeting the needs of the pharmaceutical industry.

Segmentation Analysis

The global active pharmaceutical ingredients market is segmented based on type, synthesis, manufacturer, type of drug, and geography.

By Type

Based on type, the market is segmented into generic API and branded API. The branded API segment led the market in 2023, reaching a value of USD 144.79 billion. This notable growth is attributable to several factors, including patents granting exclusivity, brand trust from established companies, ongoing research driving innovation, extensive marketing and distribution networks, as well as value-added services such as technical support. These factors combine to establish branded APIs as premium products, thereby commanding higher prices and asserting dominance in the market, particularly during the patent-protected period when there is no direct competition from generic alternatives.

By Synthesis

Based on synthesis, the market is bifurcated into synthetic and biotech. The synthetic segment held the largest revenue share of 68.64% in 2023 due to its cost-effectiveness, consistent quality, and versatility in drug design. They offer precise control over purity and potency, thereby ensuring regulatory compliance and patient safety. Synthetic APIs also exhibit better stability and scalability, meeting the demands of large-scale manufacturing and ensuring a reliable supply chain. These factors make them the preferred choice for pharmaceutical companies seeking efficient and effective medication solutions.

Active Pharmaceutical Ingredients Market Regional Analysis

Based on region, the global active pharmaceutical ingredients market is classified into North America, Europe, Asia-Pacific, MEA, and Latin America.

Active Pharmaceutical Ingredient Market Size & Share, By Region, 2024-2031

The North America Active Pharmaceutical Ingredients Market share stood around 37.06% in 2023 in the global market, with a valuation of USD 79.93 billion. This dominance in the market is due to its advanced healthcare infrastructure, substantial investments in research and development, stringent regulatory standards ensuring quality and safety, and high market demand. The market is further influenced by a diverse population, technological advancements in API production, and strategic partnerships fostering innovation and market expansion. These factors collectively contribute to North America's dominance in the API market, thereby solidifying its position as a leading region in pharmaceutical innovation and production.

Asia-Pacific is poised to witness significant growth over the forecast period at a CAGR of 8.32%. This considerable growth is propelled by the significant rise in healthcare spending, a robust market for generic drugs due to patent expirations, and established API manufacturing capabilities in countries such as India and China. The increasing prevalence of chronic diseases, ongoing technological advancements, and supportive government policies are further supporting the growth of the Asia-Pacific active pharmaceutical ingredients market.

Competitive Landscape

The global active pharmaceutical ingredients market report will provide valuable insight with an emphasis on the fragmented nature of the industry. Prominent players are focusing on several key business strategies such as partnerships, mergers and acquisitions, product innovations, and joint ventures to expand their product portfolio and increase their market shares across different regions. Strategic initiatives, including investments in R&D activities, the establishment of new manufacturing facilities, and supply chain optimization, could create new opportunities for market growth.

List of Key Companies in Active Pharmaceutical Ingredients Market

  • Pfizer Inc.
  • Novartis International AG
  • Bristol-Myers Squibb
  • Boehringer Ingelheim GmbH
  • ELI Lilly and Company
  • Merck & Co., Inc.
  • Abbvie Inc.
  • Sanofi Inc.
  • GlaxoSmithKline PLC

Key Industry Developments 

  • February 2024 (Regulations): The Food and Drug Administration (FDA)released a draft guide for drug and biological product manufacturers. This guide helps manufacturers inform the FDA promptly about any permanent stop or pause in making their products. Such information is vital for the FDA to prevent or reduce shortages of these medicines. The guide also explains how the FDA shares information about the shortage of products with the public.
  • October 2023 (Expansion): Egis, a pharmaceutical company based in Hungary, made a substantial investment to expand its research and manufacturing capabilities. These investments support the development and production of active pharmaceutical ingredients (APIs) used in treating various diseases. Egis' vertical integration and advanced technology enable efficient and high-quality API production with a major focus on safety and sustainability.

The Global Active Pharmaceutical Ingredients Market is Segmented as:

By Type

  • Generic API
  • Branded API

By Synthesis

  • Synthetic
  • Biotech

By Manufacturer

  • Captive APIs
  • Merchant APIs

By Type of Drug

  • Prescription
  • OTC

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • U.K.
    • Spain
    • Germany
    • Italy
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Check Icon Additional Company Profiles
  • Check Icon Additional Countries
  • Check Icon Cross Segment Analysis
  • Check Icon Regional Market Dynamics
  • Check Icon Country-Level Trend Analysis
  • Check Icon Competitive Landscape Customization
  • Check Icon Extended Forecast Years
  • Check Icon Historical Data Up to 5 Years
Frequently Asked Questions (FAQ's)
The global market is projected to reach USD 323.29 billion by 2031, growing at a CAGR of 5.38% from 2024 to 2031.
The global market was valued at USD 215.67 billion in 2023.
The API industry is influenced by factors such as stringent regulations, research and development (R&D), healthcare demand, patent expirations, technology, and costs.
Top manufacturers of active pharmaceutical ingredients Pfizer Inc., Novartis International AG, Bristol-Myers Squibb, BASF SE, Boehringer Ingelheim GmbH, ELI Lilly and Company, Merck & Co., Inc., Abbvie Inc., Sanofi Inc., GlaxoSmithKline PLC and others.
Asia-Pacific is the fastest growing region with the CAGR of 8.32% in the forecast period (2024-2031) with the market value forecast to reach at USD 90.33 billion.
By type, branded API will hold the maximum share in the active pharmaceutical ingredients market with the revenue value of USD 207.30 billion in 2031.
Get the latest!

Get actionable strategies to empower your business and market domination

  • Deliver Revenue Impact
  • Demand Supply Patterns
  • Market Estimation
  • Real-Time Insights
  • Market Intelligence
  • Lucrative Growth Opportunities
  • Micro & Macro Economic Factors
  • Futuristic Market Solutions
  • Revenue-Driven Results
  • Innovative Thought Leadership